Does Lefamulin 600 Mg Tablet Interact with other Medications?
Severe Interactions
These medications are not usually taken together. Consult your healthcare professional (e.g., doctor or pharmacist) for more in formation.
- ORAL LEFAMULIN/LONAFARNIB
- ORAL LEFAMULIN/SENSITIVE CYP3A4 SUBSTRATES THAT PROLONG QT
- MODERATE CYP3A4 INHIBITORS/LUMATEPERONE (>21 MG)
- STRONG OR MODERATE CYP3A4 INHIBITORS/LOMITAPIDE
- MODERATE CYP3A4 INHIBITORS/NALOXEGOL (> 12.5 MG)
- MODERATE CYP3A4 INHIBITORS/AVANAFIL (> 50 MG)
Serious Interactions
These medications may interact and cause very harmful effects. Consult your healthcare professional (e.g., doctor or pharmacist) for more in formation.
- LEFAMULIN/STRONG CYP3A4 OR P-GLYCOPROTEIN (P-GP) INDUCER
- LEFAMULIN/MODERATE CYP3A4 INDUCERS
- ORAL LEFAMULIN/SELECTED STRONG CYP3A4 INHIBITORS
- ORAL LEFAMULIN/P-GLYCOPROTEIN (P-GP) INHIBITORS
- LEFAMULIN/QT PROLONGING AGENTS
- ORAL LEFAMULIN/STRONG & MOD CYP3A4 INHIBITOR THAT PROLONG QT
- ORAL LEFAMULIN/P-GP INHIBITORS THAT PROLONG QT
- LEFAMULIN/CARBAMAZEPINE
- LEFAMULIN/STRONG OR MODERATE CYP3A4 INDUCERS THAT PROLONG QT
- SELECTED SENSITIVE P-GP AND CYP3A4 SUBSTRATES/SOTORASIB
- LEFAMULIN/MAVACAMTEN
- STRONG AND MODERATE CYP3A4 INHIBITORS/NIROGACESTAT
- MODERATE CYP3A4 INHIBITORS/LURBINECTEDIN
- SELECTED MODERATE CYP3A4 INHIBITORS/DOMPERIDONE
- ANTIBIOTICS/FECAL MICROBIOTA SPORES
- MODERATE CYP3A4 INHIBITORS & SUBSTRATES/PEXIDARTINIB
- MODERATE CYP3A4 INHIBITORS/OMAVELOXOLONE
- STRONG AND MODERATE CYP3A4 INHIBITORS/ELACESTRANT
- MODERATE CYP3A4 INHIBITORS THAT PROLONG QT/PACRITINIB
- STRONG & MODERATE 3A4 INHIB THAT PROLONG QT/ENCORAFENIB
- STRONG & MODERATE 3A4 INHIBITOR THAT PROLONG QT/FEXINIDAZOLE
- MODERATE CYP3A4 INHIBITORS/VOCLOSPORIN
- STRONG AND MODERATE CYP3A4 INHIBITORS/PRALSETINIB
- MODERATE CYP3A4 INHIBITORS THAT PROLONG QT/SELPERCATINIB
- ORAL LEFAMULIN/SLT SENSITIVE 3A4 SUBSTRATES THAT INHIBIT 3A4
- ORAL LEFAMULIN/SELECTED SENSITIVE CYP3A4 SUBSTRATES
- MODERATE CYP3A4 INHIBITORS/VENETOCLAX
- MODERATE CYP3A4 INHIBITORS/NALOXEGOL (<= 12.5 MG)
- STRONG OR MODERATE CYP3A4 INHIBITORS/SIMEPREVIR
- MODERATE CYP3A4 INHIBITORS/TOLVAPTAN
- SELECTED QT PROLONGING AGENTS/ZIPRASIDONE
- POSSIBLE QT PROLONGING AGENTS/SERTINDOLE
- SELECTED MODERATE CYP3A4 INHIBITORS/EPLERENONE
Moderate Interactions
These medications may cause some risk when taken together. Consult your healthcare professional (e.g., doctor or pharmacist) for more in formation.
- ORAL LEFAMULIN/MODERATE CYP3A4 INHIBITORS
- LEFAMULIN/POSSIBLE QT PROLONGING AGENTS
- POSSIBLE QT PROLONGING AGENTS/DEXMEDETOMIDINE SUBLINGUAL
- MODERATE CYP3A4 INHIBITORS/MACITENTAN
- MODERATE CYP3A4 INHIBITORS/FINERENONE
- MODERATE CYP3A4 INHIBITORS/CAPIVASERTIB
- SELECTED MODERATE CYP3A4 INHIBITORS/CYCLOSPORINE
- STRONG AND MODERATE 3A4 INHIBITORS THAT PROLONG QT/ETRASIMOD
- MODERATE CYP3A4 INHIBITORS/PALOVAROTENE
- MODERATE CYP3A4 INHIBITORS/LAROTRECTINIB
- QT PROLONGING AGENTS/TUCIDINOSTAT
- MODERATE CYP3A4 INHIBITORS/LUMATEPERONE (<=21 MG)
- QT PROLONGING AGENTS/TRICLABENDAZOLE
- QT PROLONGING AGENTS/OZANIMOD
- QT PROLONGING AGENTS/PONESIMOD
- QT PROLONGING AGENTS/SIPONIMOD
- QT PROLONGING AGENTS/GALANTAMINE
- POSSIBLE QT PROLONGING AGENTS/LEVOMEPROMAZINE
- STRONG OR MODERATE CYP2D6 OR CYP3A4 INHIBITORS/OLICERIDINE
- POSSIBLE QT PROLONGING AGENTS/OXALIPLATIN
- QT PROLONGING AGENTS/OSILODROSTAT
- QT PROLONGING AGENTS/AMISULPRIDE
- MODERATE CYP3A4 INHIBITORS/AVANAFIL (<= 50 MG)
- MODERATE CYP3A4 INHIBITORS/IBRUTINIB
- QT PROLONGING AGENTS/FINGOLIMOD
- POSSIBLE QT PROLONGING AGENTS/GADOFOSVESET
Selected from data included with permission and copyrighted by First Databank, Inc. This copyrighted material has been downloaded from a licensed data provider and is not for distribution, except as may be authorized by the applicable terms of use.
CONDITIONS OF USE: The information in this database is intended to supplement, not substitute for, the expertise and judgment of healthcare professionals. The information is not intended to cover all possible uses, directions, precautions, drug interactions or adverse effects, nor should it be construed to indicate that use of a particular drug is safe, appropriate or effective for you or anyone else. A healthcare professional should be consulted before taking any drug, changing any diet or commencing or discontinuing any course of treatment.